drugset / Trial / NCT01745159

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

NCT01745159 ↗

Phase 4 Completed 125 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess if proactive, 2 times-weekly application of tacrolimus ointment can extend remission time to relapse and reduce the incidence of disease exacerbation (DE) in paediatric patients over a period of 6 months.

Timeline

Start
2012-09
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —

Indications